Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System

NCT02798328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 385

Last updated 2020-02-11

No results posted yet for this study

Summary

Observational trial to evaluate the effectiveness of the TEG6s DOAC cartridge to detect and classify the presence of DOAC drugs in a subject.

Conditions

  • DOAC Eligible Subjects

Interventions

DEVICE

TEG6s DOAC Cartridge

Testing subjects for presence of DOAC

Sponsors & Collaborators

  • Haemonetics Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798328 on ClinicalTrials.gov